Runway Growth Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
VERO Biotechvero-biotech.cominJan 2021 · $50M
VERO Biotech develops next-generation inhaled nitric oxide (iNO) delivery systems for patients with cardiopulmonary conditions in acute care hospital settings.
BiotechHealthtechMedical Devices
Co-investorsBrace PharmaMVM Life Science Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.